G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting - Associated Press

-
G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting  Associated Press

Press release *content* from Globe Newswire. The AP news staff was not involved in its creation.



Comments

Post a Comment

Popular posts from this blog

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

-
Image
kathy lung cancer :: Article Creator Kathy Griffin Reveals Theory Her Lung Cancer Was Caused By Poisoning Kathy Griffin Reveals Theory Her Lung Cancer Was Caused by Poisoning SHARE SHARE TWEET SHARE EMAIL What to watch next Prince Harry Ghostwriter's Poorly Timed Swipe At Royals Newsweek Experts Say Russia Could Be In Trouble As Elites Look Escape 'Sinking Ship' Newsweek Jim Jordan's FBI Whistleblower Hearing Descends Into Chaos Newsweek Adidas Boycott Calls Grow Over Women's Swimsuit Modeled By Biological Male Newsweek General Testifies For House Armed Services Committee Newsweek Israeli Nationalist Gather For 'Flag March' In Jerusalem Newsweek Marjorie Taylor Greene Calls For Trump-Appointed FBI Director's Impeachment Newsweek Declawed Rescue Cat Dumped at Shelter Finally Gets A Name: 'Suits Him' Newsw...
Read more

Oncology: The disease, dynamics & challenges of market research

-
Image
inoperable small cell lung cancer :: Article Creator Inoperable Lung Cancer Inoperable lung cancer is a tumor that surgery can't treat. This might be because the cancer is in a hard-to-reach spot or for other reasons, like if it's spread outside your lungs. It's also called unresectable lung cancer. Just because you can't have surgery doesn't mean you can't do anything about the cancer. Treatments like radiation, chemotherapy, targeted therapy, and immunotherapy can fight it, even when an operation isn't an option. There are two main types of lung cancer, based on the size and other factors of the affected cells: Non-small-cell lung cancer (NSCLC). Up to 85% of lung cancer cases are this kind. It has three subtypes: Adenocarcinoma. This starts in cells that make things like mucus. It's often found in the outer parts of your lung, many times before it has spread. Squamous cell carcinoma. This begins in th...
Read more

Respirology | APSR Respiratory Medicine Journal

-
Image
types of lung diseases and disorders :: Article Creator Lung Disease News Feb. 19, 2025 — A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ... Feb. 18, 2025 — Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the ... Feb. 14, 2025 — A study has found microscopic particles emitted from certain types of commonly fitted brake pads can be more toxic than those found in diesel vehicle ... Feb. 10, 2025 — Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth. The enzyme, GUK1, supports metabolism in cancer cells to help tumors ... Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in lif...
Read more